We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Alkemy Capital Investments PLC 26 February 2024 26 February 2024 Alkemy Capital Investments Plc Appointment of Zeus Capital as Financial Adviser and Corporate Broker Alkemy Capital...
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by A ...
Alkemy Capital Investments PLC 30 January 2024 30 January 2024 Alkemy Capital Investments Plc Tees Valley Graphite executes MOU with Syrah Resources to develop graphite processing...
TIDMB -- Studiet fortsætter nu i sin anden del, som forventes afsluttet senere i 2024. -- ALK indsender protokolændring for at udvide studiet til et fase 1-2 effektstudie. ALK (ALKB:DC...
TIDMB -- The trial now progresses into its second part, expected to complete later in 2024. -- ALK to submit a protocol amendment for Phase 1-2 efficacy trial extension. ALK (ALKB:DC / OMX: ALK B...
vestments PLC - London-based company focused on acquisitions in the mining and technology metals sectors - Believes ma ...
Alkemy Capital Investments PLC 18 January 2024 18 January 2024 Alkemy Capital Investments Plc Corporate Update Alkemy Capital Investments plc ("Alkemy") (LSE: ALK) (FRA:JV2) is pleased...
TIDMB -- PRE-PEN(R) (benzylpenicilloyl polylysine injection USP) is the only FDA-approved diagnostic skin test for the evaluation of penicillin allergy(i) (,) (ii) -- The Danish, pharmaceutical...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 5 | 5.88235294118 | 85 | 90 | 85 | 23744 | 87.38464357 | DE |
4 | 7.5 | 9.09090909091 | 82.5 | 95 | 76.5 | 35582 | 85.38677143 | DE |
12 | -2.5 | -2.7027027027 | 92.5 | 95 | 72.5 | 43794 | 82.51257245 | DE |
26 | -35 | -28 | 125 | 142.5 | 72.5 | 44533 | 100.50740405 | DE |
52 | -170 | -65.3846153846 | 260 | 265 | 72.5 | 40144 | 125.85741236 | DE |
156 | 30 | 50 | 60 | 380 | 60 | 33729 | 154.47788133 | DE |
260 | 30 | 50 | 60 | 380 | 60 | 33729 | 154.47788133 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions